Tesa is hyped as reducing VAT because influencers skew the findings and ignore the fundamental question you can ask any AI.
“By what mechanism does Tesa reduce visceral fat, use only preclinical and clinical studies published in reputable journals, no blogs, no influencers, no clinics, no YouTube videos” if you don’t use the guardrail you will get all the paid promotional BS.
Fundamentally, Tesa does not reduce adipose tissue, when you ask the right question, the answer is hGH, human growth hormone. Which when it rises, naturally raises IGF-1. to push hGH down and IGF-1 then follows hGH down.
Basically any way you increase hGH will reduce VAT (visceral adipose tissue). Pulsitile hGH is probably safer than extended high levels of hGH and that is what Tesa and the combo below do. Tesa has a short half life of about 2 hours, the combo below has a half life of about 2 hours. And produces a higher peak and more area under the curve when used to support the natural circadian cycle of you hGH production 2 to 3 hours after going to sleep
I’ve been using Ipamorelin and CJC noDAC for nearly 3 years, plus Retatrutide and even though I have not had a DEXA and the scales that “estimate” visceral fat are not accurate, they do show trends.
My VAT according the the Renpho 8 lead scale is 3, my wife is 2.
Ultrasound-detected hepatic steatosis in normal-weight adults without diagnosed diabetes or conventional hypertension: burden and metabolic phenotype in 93,562 health examinees
Hepatic steatosis was detected in 33,042 participants (35.3%). Among 54,438 normal-weight participants, 9,700 had steatosis (17.8%, 95% confidence interval [CI] 17.5%–18.1%) and accounted for 29.4% of all cases. Participants with normal weight and steatosis had greater waist circumference and less favorable lipid, uric-acid, liver-enzyme, and insulin-resistance-related measures than those without.
Conclusions
Ultrasound-detected hepatic steatosis was common and metabolically unfavorable among normal-weight adults without diagnosed diabetes or hypertension. Normal BMI alone should not be assumed to exclude steatosis. The reported markers should be interpreted as correlates rather than causal predictors or substitutes for liver imaging.
Best Drinks that MELT Visceral Fat (Science-Backed) (via Nutrition Made Simple!)
AI Summary Added by RapAdmin:
I. Executive Summary
Visceral adipose tissue (VAT) and ectopic intrahepatic fat (IHF) are primary drivers of hepatic insulin resistance, systemic low-grade inflammation, cardiometabolic disease, and type 2 diabetes. The presented video evaluates nine candidate functional beverages purported to reduce visceral and intrahepatic adiposity, categorizing their efficacy through human clinical trials and mechanistic biochemistry. The central argument posits that while lifestyle hypocaloric interventions induce modest hepatic and visceral fat loss, targeted polyphenol and prebiotic fiber supplementation can amplify these reductions through distinct metabolic and microbiological pathways, independent of substantial caloric restriction.
The premier human trial cited is the 18-month DIRECT-PLUS randomized controlled trial (Yaskolka Meir et al., 2021), which demonstrated that an isocaloric “Green-Mediterranean” diet enriched with 3–4 daily cups of green tea and 100 g/day frozen Mankai (Wolffia globosa duckweed shake, delivering approximately 1,240 mg/day of total polyphenols) induced an intrahepatic fat reduction of 38.9%, compared to 19.6% with a standard Mediterranean diet and 12.2% with standard dietary guidelines, while doubling visceral fat regression.
The physiological drivers behind these interventions fall into three categories:
Catechin-Rich Polyphenols: Concentrated epigallocatechin gallate (EGCG) suppresses hepatic lipogenesis, enhances lipid beta-oxidation via AMP-activated protein kinase (AMPK) phosphorylation, and elevates thermogenesis.
Prebiotic and Fermentable Substrates: Type 2 resistant starch (RS2) and resistant maltodextrin (RMD) bypass upper intestinal digestion to undergo colonic bacterial fermentation, producing short-chain fatty acids (SCFAs—notably acetate, propionate, and butyrate) that upregulate GLP-1/PYY satiety cascades and modulate gut-liver axis lipid accumulation.
Isocaloric Protein Substitution: High-protein shakes augment satiety and maintain skeletal muscle nitrogen balance during caloric deficits.
However, translational gaps remain pronounced. A Cochrane systematic review (Jurgens et al., 2012) establishes that green tea preparations induce small, clinically borderline reductions in global weight loss, underscoring that polyphenolic efficacy is depot-specific rather than a generic metabolic panacea. Concentrated green tea extract powders also carry idiosyncratic hepatotoxicity risks. Overall, beverages serve as targeted marginal amplifiers—effective primarily when replacing obesogenic, high-sugar, or alcohol-containing liquids—rather than autonomous cures for visceral adiposity.
Visceral and hepatic adipose depots demonstrate higher lipolytic sensitivity and vascularization compared to subcutaneous fat, rendering them paradoxically more responsive to dietary and lifestyle modulation.
The 18-month DIRECT-PLUS randomized controlled trial demonstrated that adding a polyphenol cocktail to an isocaloric Mediterranean diet doubled intrahepatic fat reduction compared to standard diet and exercise alone (Yaskolka Meir et al., 2021).
In the DIRECT-PLUS trial, the standard Mediterranean diet group lost 19.6% of liver fat, whereas the Green-Mediterranean cocktail group achieved a 38.9% reduction.
Visceral adipose tissue area regression was doubled in the Green-Mediterranean group (14% reduction) compared to the standard Mediterranean intervention (7% reduction) (Yaskolka Meir et al., 2021).
The intervention beverage cocktail consisted of 3 to 4 cups of green tea daily combined with a green shake derived from the aquatic plant duckweed (Wolffia globosa, commercially termed Mankai).
The experimental shake was integrated isocalorically: dietary energy intake was matched between intervention arms by subtracting an equivalent calorie amount of solid dinner food.
Plant polyphenols exert hepatoprotective effects by attenuating oxidative stress in hepatocytes, downregulating lipogenic enzyme pathways, and enhancing mitochondrial beta-oxidation (Beneficial Effects of Tea and Catechins, PMC6274011).
Duckweed / Mankai delivers bioavailable complete plant protein, dietary fiber, vitamin B12, iron, and a dense flavonoid profile dominated by kaempferol and luteolin glycosides.
While the clinical trial utilized 100 g/day of whole frozen plant cubes, the equivalent dose of dehydrated Wolffia globosa powder is estimated at approximately 5 g/day (one heaping teaspoon).
The primary metabolic impact of functional beverage interventions occurs when substituting for obesogenic liquids, specifically sugar-sweetened beverages and alcohol.
Meta-analyses of randomized trials demonstrate that green tea catechins elicit modest but statistically significant reductions in visceral fat area and waist circumference (Nagao et al., 2007).
Catechins, particularly epigallocatechin-3-gallate (EGCG), upregulate hepatic AMPK pathways and suppress fatty acid synthase (FAS), diminishing de novo lipogenesis.
Standard commercial bagged tea infusions exhibit highly variable catechin yields, frequently falling below the 400–800 mg therapeutic threshold utilized in clinical literature.
Standardized bottled green tea formulations containing declared catechin metrics, such as Ito En, guarantee reproducible polyphenol ingestion.
High-potency green tea extract capsules manufactured by supplement brands, such as NOW Foods, typically deliver standardized 80% total catechins.
Matcha tea powder provides a significantly higher catechin-to-volume ratio than water-extracted green tea infusions because the entire Camellia sinensis leaf is ground and consumed.
Cocoa powder delivers concentrated flavan-3-ols (epicatechin and catechin) that modulate insulin sensitivity and vascular endothelial function, though human visceral fat outcomes show lower effect sizes than green tea (Cocoa Polyphenols and Metabolism).
Coffee enriched with chlorogenic acids (CGA) has demonstrated modest reductions in visceral fat storage, but commercial roasting degradation makes clinical outcomes variable (Coffee CGA Trial, PubMed).
Clove tea provides eugenol, an exceptionally potent antioxidant polyphenol; however, direct human randomized controlled trials confirming reductions in human visceral fat remain unverified in live search.
Dietary protein shakes promote visceral fat reduction when used as an isocaloric or hypocaloric meal replacement due to the high thermic effect of food (TEF) and enhanced satiety.
High dietary protein triggers peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) release while suppressing circulating ghrelin.
Type 2 resistant starch (RS2) bypasses human enzymatic amylolysis in the upper digestive tract, reaching the cecum and colon intact.
RS2 sources include unmodified raw potato starch (containing 50% to 75% resistant starch by mass) and green banana flour (30% to 55% resistant starch).
Colonic microbial fermentation of RS2 produces short-chain fatty acids (acetate, propionate, butyrate), which downregulate hepatic lipogenesis and enhance peripheral insulin sensitivity (Resistant Starch Human Trial, Cell Metabolism).
Clinical protocols evaluating RS2 for metabolic modulation typically administer doses between 30 and 40 grams of net resistant starch per day.
Abrupt introduction of high-dose resistant starch generates gastrointestinal distress, bacterial gas production, and flatulence, requiring incremental upward titration.
Resistant maltodextrin (RMD) is a non-viscous, water-soluble dietary fiber derived from partially hydrolyzed starch that resists small-intestinal digestion (PubMed 33132344).
Placebo-controlled clinical trials indicate that continuous consumption of resistant maltodextrin at doses of 9 g to 27 g per day reduces visceral adipose tissue area by 5% to 20% in subjects with abdominal obesity (ACS J. Agric. Food Chem.).
Unlike native resistant starch, resistant maltodextrin dissolves fully in aqueous solutions without gelatinization or significant viscosity changes.
Green tea catechins, isocaloric protein substitution, and RS2 exhibit the strongest quantitative human clinical trial backing for reducing visceral/ectopic fat depots.
Mankai duckweed, raw cocoa flavanols, and resistant maltodextrin maintain intermediate confidence due to smaller trial counts or formulation dependencies.
Matcha, clove tea, and chlorogenic acid-rich coffee represent mechanistic extrapolations with limited isolated randomized controlled trial validation for visceral adiposity.
Visceral fat reduction can occur under isocaloric macronutrient and phytochemical substitution without requiring severe intentional caloric restriction.
Dietary interventions targeting visceral fat frequently show substantial inter-individual variability, largely governed by baseline gut microbiome composition and liver fat severity.
Free home anthropometric metrics, including waist-to-height ratio and waist circumference, provide practical surrogates for tracking visceral adiposity shifts in the absence of MRI/MRS imaging.
IV. Actionable Protocol (Prioritized)
High Confidence Tier (Level A/B Evidence)
Standardized High-Catechin Green Tea / EGCG:
Dosing: Ingest 3 to 4 cups of brewed green tea daily, or a standardized beverage supplying 400–800 mg total catechins per day (Nagao et al., 2007).
Implementation: Consume between meals. If substituting for morning or afternoon sugary drinks, ensure zero added sucrose or caloric sweeteners.
Isocaloric Protein Replacement:
Dosing: 25–40 g of high-quality protein (whey isolate or soy/pea isolate) prepared in water.
Implementation: Must replace an equivalent caloric intake of refined carbohydrates or dietary fat rather than adding surplus calories on top of baseline intake.
Type 2 Resistant Starch (RS2) Supplementation:
Dosing: 20–40 g total powder daily (e.g., raw unmodified potato starch or green banana flour) mixed into unheated liquids (Cell Metabolism RS Trial).
Titration: Initiate at 5 g/day for 7 days; titrate upward by 5 g weekly to mitigate microbial gas production and bloating. Never expose to heat exceeding 60°C to prevent starch gelatinization and destruction of resistant crystalline structures.
Experimental Tier (Level C/D Evidence / High Safety Margin)
Duckweed (Wolffia globosa / Mankai):
Dosing: Approximately 5 g of dehydrated powder (equivalent to 100 g frozen whole plant) once daily blended in water (Yaskolka Meir et al., 2021).
Caveat: Replicates the DIRECT-PLUS cocktail, though access to standardized sources remains limited commercially outside select suppliers.
Resistant Maltodextrin (RMD):
Dosing: 10–25 g/day divided across 2–3 servings dissolved in cold or warm beverages (PubMed 33132344).
Safety: High tolerability profile compared to intact resistant starch; lower incidence of rapid gas fermentation.
Whole-Leaf Matcha & Pure Cocoa:
Dosing: 1–2 g ceremonial/culinary grade matcha powder; 10–15 g non-alkalized (natural) dark cocoa powder daily.
Rationale: Elevated flavanol density; however, dedicated human RCTs isolating visceral fat loss endpoints are limited compared to green tea extracts.
Red Flag Zone (Debunked or Lacking Safety Data)
High-Dose Green Tea Extract (GTE) Capsules on an Empty Stomach:
Risk: Concentrated bolus supplements of EGCG exceeding 800 mg/day—particularly when consumed during prolonged fasting—carry documented risks of acute idiosyncratic hepatotoxicity and elevated serum aminotransferases (EFSA Scientific Opinion on Green Tea Catechins). Whole brewed tea or fed-state ingestion is clinically preferred.
Clove Infusions for Targeted Visceral Fat Loss:
Status:Source unverified in live search. Human randomized clinical trials demonstrating isolated reduction of visceral or intrahepatic fat by clove tea are absent. High ingestion of concentrated clove essential oils poses mucosal and liver toxicity risks.
Over-the-Counter “Detox” Cleanses:
Status: Debunked. No clinical evidence supports non-prescriptive commercial detox drinks for visceral or intrahepatic adipose loss.
I read a article once, the researchers said the reasons why fat is harmful is because of the “glycerol backbone”, the more glycerol in your body, the shorter you live.
